AlloTec is revolutionizing the understanding and modulation of protein-protein interactions pivotal in oncology, inflammation, and autoimmune diseases through the integration of cutting-edge machine learning, molecular simulation, and experimental techniques. Our mission is to decipher the complexities of allosteric interactions and their influence on protein-protein interactions, leveraging our pioneering computational assay platform to elucidate the intricate mechanisms by which drug binding induces conformational shifts in proteins. These shifts are critical for modulating disease pathways, offering novel therapeutic insights and intervention strategies.
At AlloTec, we are not just innovators in technology; we are advocates for transparency and collaboration in the scientific community. We pledge to share our discoveries through peer-reviewed publications, engaging blogs, and by making our source codes accessible to the public. Through our efforts, we aim to foster a more informed and cooperative scientific environment, driving forward the discovery of groundbreaking treatments for some of the most challenging diseases.
AlloTec 